Danam Health, Inc. Finalizes Acquisition of Wellgistics
Danam Health, Inc. today announced it has completed the acquisition of Wellgistics, LLC. Wellgistics is an FDA-licensed, NABP-accredited pharmaceutical wholesaler and distributor with operations across all 50 states. With this move, Wellgistics becomes part of Danam Health’s expanding portfolio, which also grew with the recent acquisition of Wood Sage, LLC.
Expanding Reach and Capabilities
Bringing Wellgistics into Danam aligns with the company’s push to build a more complete healthcare ecosystem. Wellgistics connects small and mid-size pharmaceutical manufacturers with independent retail pharmacies, improving access to essential medications where people fill their prescriptions. The acquisition is expected to strengthen Danam’s position in pharmaceutical distribution and deepen its ability to serve both sides of the market.
Leadership Perspectives
Brian Norton, CEO of Wellgistics, shared that the deal allows the team to broaden its focus and double down on serving independent retail pharmacies. The integration, he noted, opens the door to question old assumptions and pursue better ways of working across the industry.
Wellgistics’ Role Inside Danam Health
Wellgistics already supports more than 60 pharmaceutical manufacturers and over 4,000 independent pharmacies. Through distribution and third-party logistics (3PL) services, the company helps niche therapeutic products reach the shelves and stay visible, creating clearer pathways to market access for manufacturers and reliable supply for pharmacies.
Investment in Infrastructure
Wellgistics’ recent investments in cold chain logistics are expected to materially expand Danam’s capabilities, especially in specialty-lite therapies. These upgrades support efficient handling of a wider mix of branded products and reinforce Wellgistics’ position as a core building block within the Danam Health ecosystem.
A Vision for Integrated Care
Tim Canning, CEO of Danam Health, emphasized that adding Wellgistics—alongside the Wood Sage acquisition—advances the company’s plan to create a seamless prescription ecosystem. The model brings together technology, fulfillment networks, and wholesale distribution with a focus on specialty-lite medications. The aim: a clearer path from prescription to patient, with better outcomes along the way.
About Danam Health, Inc.
Founded in 2022, Danam Health, Inc. is a holding company for strategic healthcare businesses. Centered on pharmaceuticals and healthcare services, Danam focuses on reshaping the patient care dynamic. Its solutions are designed for pharmacies, healthcare providers, pharmaceutical manufacturers, and payors—meeting each where they operate today, and helping them move forward together.
Frequently Asked Questions
Why does Danam Health’s acquisition of Wellgistics matter?
It expands Danam’s distribution reach and strengthens support for independent pharmacies, helping essential medications move more efficiently from manufacturers to the communities that depend on them.
How will Wellgistics contribute within Danam Health?
Wellgistics brings nationwide distribution and 3PL services, serving over 60 manufacturers and more than 4,000 independent pharmacies. That combination improves product visibility, access, and day-to-day logistics.
What changes should I expect post-acquisition?
Danam plans to integrate Wellgistics’ logistics strengths with its technology, fulfillment networks, and wholesale distribution—especially around specialty-lite medications—to streamline how prescriptions get filled.
Who is Brian Norton, and what’s his focus?
Brian Norton is the CEO of Wellgistics. He’s focused on broadening the company’s efforts while reinforcing its commitment to independent retail pharmacies.
What’s Danam Health’s broader goal?
Danam aims to reshape care around the patient by bringing together pharmaceuticals and healthcare services, with solutions designed for pharmacies, providers, manufacturers, and payors.
